Identification	O
of	O
a	O
physical	O
interaction	O
between	O
calcineurin	B-protein
and	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
(	O
NFATp	B-protein
)	O
.	O

In	O
T	B-cell_type
lymphocytes	I-cell_type
,	O
the	O
calcium/calmodulin-dependent	B-protein
serine/threonine	I-protein
phosphatase	I-protein
,	O
calcineurin	B-protein
,	O
plays	O
a	O
pivotal	O
role	O
in	O
transducing	O
membrane-associated	O
signals	O
to	O
the	O
nucleus	O
.	O

One	O
of	O
the	O
putative	O
targets	O
of	O
calcineurin	B-protein
is	O
the	O
pre-existing	O
,	O
cytosolic	B-protein
component	I-protein
of	O
the	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
(	O
NFATp	B-protein
;	O
also	O
referred	O
to	O
as	O
NFAT1	B-protein
)	O
,	O
which	O
is	O
one	O
of	O
several	O
transcription	B-protein
factors	I-protein
required	O
for	O
the	O
expression	O
of	O
interleukin	B-protein
2	I-protein
.	O

Inhibition	O
of	O
calcineurin	B-protein
by	O
the	O
immunosuppressive	O
drugs	O
cyclosporin	O
A	O
and	O
FK506	O
prevents	O
dephosphorylation	O
of	O
NFATp	B-protein
and	O
its	O
translocation	O
to	O
the	O
nucleus	O
.	O

However	O
,	O
a	O
physical	O
interaction	O
between	O
calcineurin	B-protein
and	O
NFATp	B-protein
has	O
not	O
been	O
demonstrated	O
.	O

Here	O
we	O
demonstrate	O
the	O
binding	O
of	O
NFATp	B-protein
from	O
lysates	O
of	O
T	B-cell_type
cells	I-cell_type
to	O
immobilized	O
calcineurin	B-protein
.	O

Stimulation	O
of	O
T	B-cell_type
cells	I-cell_type
with	O
calcium	O
ionophore	O
induced	O
a	O
shift	O
in	O
the	O
molecular	O
weight	O
of	O
NFATp	B-protein
that	O
is	O
due	O
to	O
its	O
dephosphorylation	O
.	O

This	O
dephosphorylation	O
was	O
inhibited	O
by	O
treatment	O
of	O
T	B-cell_type
cells	I-cell_type
with	O
cyclosporin	O
A	O
or	O
FK506	O
prior	O
to	O
stimulation	O
.	O

Of	O
note	O
,	O
both	O
the	O
phosphorylated	O
and	O
the	O
dephosphorylated	O
form	O
of	O
NFATp	B-protein
bound	O
to	O
calcineurin	B-protein
.	O

Furthermore	O
,	O
the	O
binding	O
of	O
both	O
forms	O
of	O
NFATp	B-protein
to	O
calcineurin	B-protein
was	O
inhibited	O
by	O
pretreatment	O
of	O
calcineurin	B-protein
with	O
a	O
complex	O
of	O
FK506	O
and	O
its	O
ligand	O
FKBP12	O
.	O

Taken	O
together	O
these	O
data	O
strongly	O
suggest	O
a	O
direct	O
interaction	O
of	O
calcineurin	B-protein
with	O
NFATp	B-protein
and	O
that	O
this	O
interaction	O
does	O
not	O
depend	O
upon	O
the	O
phosphorylation	B-DNA
sites	I-DNA
of	O
NFATp	B-protein
affected	O
by	O
activation	O
.	O

Communication	NULL
Identification	NULL
of	NULL
a	NULL
Physical	NULL
Interaction	NULL
between	NULL
Calcineurin	NULL
and	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
(	NULL
NFATp	NULL
)	NULL
*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
September	NULL
14	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
November	NULL
9	NULL
,	NULL
1995	NULL
)	NULL
Sebastian	NULL
Wesselborg	NULL
?	NULL

,	NULL
David	NULL
A	NULL
.	NULL

Fruman	NULL
?	NULL
}	NULL

,	NULL
Jasbir	NULL
K.	NULL
Sagoo	NULL
$	NULL
,	NULL
Barbara	NULL
E.	NULL
Bierer	NULL
#	NULL
§	NULL
,	NULL
and	NULL
Steven	NULL
J	NULL
.	NULL

Burakoff	NULL
?	NULL
]	NULL

**	NULL
From	NULL
the	NULL
{	NULL
Division	NULL
of	NULL
Pediatric	NULL
Oncology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
and	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Pediatrics	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
In	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
calcium/calmodulin-dependent	NULL
serine/threonine	NULL
phosphatase	NULL
,	NULL
calcineurin	NULL
,	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
transducing	NULL
membrane-associated	NULL
signals	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

One	NULL
of	NULL
the	NULL
putative	NULL
targets	NULL
of	NULL
calcineurin	NULL
is	NULL
the	NULL
pre-existing	NULL
,	NULL
cytosolic	NULL
component	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFATp	NULL
;	NULL
also	NULL
referred	NULL
to	NULL
as	NULL
NFAT1	NULL
)	NULL
,	NULL
which	NULL
is	NULL
one	NULL
of	NULL
several	NULL
transcription	NULL
factors	NULL
required	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
interleukin	NULL
2	NULL
.	NULL

Inhibition	NULL
of	NULL
calcineurin	NULL
by	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
prevents	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
p	NULL
and	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

However	NULL
,	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
calcineurin	NULL
and	NULL
NFATp	NULL
has	NULL
not	NULL
been	NULL
demonstrated	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
the	NULL
binding	NULL
of	NULL
NFAT	NULL
p	NULL
from	NULL
lysates	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
immobilized	NULL
calcineurin	NULL
.	NULL

Stimulation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
calcium	NULL
ionophore	NULL
induced	NULL
a	NULL
shift	NULL
in	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
NFAT	NULL
p	NULL
that	NULL
is	NULL
due	NULL
to	NULL
its	NULL
dephosphorylation	NULL
.	NULL

This	NULL
dephosphorylation	NULL
was	NULL
inhibited	NULL
by	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
cyclosporin	NULL
A	NULL
or	NULL
FK506	NULL
prior	NULL
to	NULL
stimulation	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
both	NULL
the	NULL
phosphorylated	NULL
and	NULL
the	NULL
dephosphorylated	NULL
form	NULL
of	NULL
NFATp	NULL
bound	NULL
to	NULL
calcineurin	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
both	NULL
forms	NULL
of	NULL
NFATp	NULL
to	NULL
calcineurin	NULL
was	NULL
inhibited	NULL
by	NULL
pretreatment	NULL
of	NULL
calcineurin	NULL
with	NULL
a	NULL
complex	NULL
of	NULL
FK506	NULL
and	NULL
its	NULL
ligand	NULL
FKBP12	NULL
.	NULL

Taken	NULL
together	NULL
these	NULL
data	NULL
strongly	NULL
suggest	NULL
a	NULL
direct	NULL
interaction	NULL
of	NULL
calcineurin	NULL
with	NULL
NFATp	NULL
and	NULL
that	NULL
this	NULL
interaction	NULL
does	NULL
not	NULL
depend	NULL
upon	NULL
the	NULL
phos-phorylation	NULL
sites	NULL
of	NULL
NFAT	NULL
p	NULL
affected	NULL
by	NULL
activation	NULL
.	NULL

The	NULL
calcium/calmodulin-dependent	NULL
serine/threonine	NULL
phosphatase	NULL
calcineurin	NULL
(	NULL
PP2B	NULL
)	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Calcineurin	NULL
(	NULL
CN	NULL
)	NULL
is	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
het-	NULL
*This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
German	NULL
Bundesministerium	NULL
fiir	NULL
Bildung	NULL
und	NULL
Forschung	NULL
(	NULL
to	NULL
S.	NULL
W.	NULL
)	NULL
and	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
Al	NULL
32514	NULL
(	NULL
to	NULL
B.	NULL
E	NULL
.	NULL

B	NULL
.	NULL
)	NULL

.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

«	NULL
Established	NULL
investigator	NULL
of	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
.	NULL

**	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Division	NULL
of	NULL
Pediatric	NULL
Oncology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Inst	NULL
.	NULL

,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
617-632-3564	NULL
;	NULL
Fax	NULL
:	NULL
617-632-4867	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
CN	NULL
,	NULL
calcineurin	NULL
;	NULL
CaM	NULL
,	NULL
calmodulin	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
FKBP	NULL
,	NULL
FK506-binding	NULL
protein	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

THe	NULL
JourNaL	NULL
or	NULL
BroLoGIcaL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

3	NULL
,	NULL
Issue	NULL
of	NULL
January	NULL
19	NULL
,	NULL
pp	NULL
.	NULL

1274-1277	NULL
,	NULL
1996	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc	NULL
.	NULL

Printed	NULL
in	NULL
U.S.A.	NULL
erodimer	NULL
,	NULL
composed	NULL
of	NULL
a	NULL
59-kDa	NULL
calmodulin-binding	NULL
catalytic	NULL
subunit	NULL
and	NULL
a	NULL
19-kDa	NULL
Ca**-binding	NULL
regulatory	NULL
subunit	NULL
that	NULL
is	NULL
required	NULL
for	NULL
enzymatic	NULL
activity	NULL
.	NULL

The	NULL
central	NULL
role	NULL
of	NULL
calcineurin	NULL
in	NULL
T	NULL
cell	NULL
signaling	NULL
was	NULL
appreciated	NULL
by	NULL
its	NULL
identification	NULL
as	NULL
the	NULL
target	NULL
of	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
and	NULL
FK506	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
phosphatase	NULL
activity	NULL
of	NULL
CN	NULL
is	NULL
inhibited	NULL
by	NULL
either	NULL
drug	NULL
when	NULL
complexed	NULL
to	NULL
intracellular	NULL
binding	NULL
proteins	NULL
(	NULL
immunophilins	NULL
)	NULL
,	NULL
i.e	NULL
.	NULL

CsA	NULL
to	NULL
cyclophilin	NULL
and	NULL
FK506	NULL
to	NULL
the	NULL
FK506-binding	NULL
protein	NULL
12	NULL
(	NULL
FKBP12	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Neither	NULL
drug	NULL
nor	NULL
immunophilin	NULL
alone	NULL
bind	NULL
to	NULL
or	NULL
affect	NULL
the	NULL
activity	NULL
of	NULL
CN	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
T	NULL
lymphocytes	NULL
both	NULL
CsA	NULL
and	NULL
FK506	NULL
inhibit	NULL
a	NULL
variety	NULL
of	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

A	NULL
well	NULL
characterized	NULL
example	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
CsA	NULL
and	NULL
FK506	NULL
is	NULL
the	NULL
inhibition	NULL
of	NULL
T	NULL
cell	NULL
receptor-mediated	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
putative	NULL
targets	NULL
of	NULL
calcineurin	NULL
is	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
(	NULL
6	NULL
)	NULL
,	NULL
which	NULL
regulates	NULL
,	NULL
in	NULL
part	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cytokine	NULL
genes	NULL
including	NULL
IL-2	NULL
,	NULL
IL-3	NULL
(	NULL
7	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulat-ing	NULL
factor	NULL
(	NULL
7	NULL
)	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
NFAT	NULL
consists	NULL
of	NULL
a	NULL
pre-existing	NULL
,	NULL
cytoplasmic	NULL
component	NULL
and	NULL
an	NULL
ubiquitously	NULL
expressed	NULL
nuclear	NULL
component	NULL
,	NULL
which	NULL
contains	NULL
members	NULL
of	NULL
the	NULL
AP1	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

NFATp	NULL
is	NULL
one	NULL
of	NULL
several	NULL
isoforms	NULL
of	NULL
the	NULL
cytosolic	NULL
component	NULL
of	NULL
NFAT	NULL
(	NULL
13-16	NULL
)	NULL
.	NULL

Increases	NULL
in	NULL
intracellular	NULL
calcium	NULL
induce	NULL
the	NULL
translocation	NULL
of	NULL
the	NULL
cytosolic	NULL
component	NULL
of	NULL
NFAT	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
NFATp	NULL
interacts	NULL
with	NULL
the	NULL
AP1	NULL
elements	NULL
Fos	NULL
and	NULL
Jun	NULL
and	NULL
binds	NULL
to	NULL
its	NULL
cognate	NULL
DNA-binding	NULL
site	NULL
.	NULL

The	NULL
calcium-dependent	NULL
dephosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NFAT	NULL
cytoplasmic	NULL
components	NULL
are	NULL
inhibited	NULL
by	NULL
CsA	NULL
and	NULL
FK506	NULL
whereas	NULL
the	NULL
generation	NULL
of	NULL
the	NULL
nuclear	NULL
components	NULL
is	NULL
unaffected	NULL
(	NULL
11	NULL
,	NULL
17-20	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
further	NULL
demonstrated	NULL
that	NULL
CN	NULL
dephosphorylates	NULL
NFATp	NULL
in	NULL
vitro	NULL
and	NULL
that	NULL
the	NULL
dephosphorylated	NULL
form	NULL
of	NULL
NFATp	NULL
binds	NULL
with	NULL
a	NULL
higher	NULL
affinity	NULL
to	NULL
an	NULL
NFAT	NULL
oligonucleotide	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
CN	NULL
phosphatase	NULL
activity	NULL
correlates	NULL
with	NULL
T	NULL
cell	NULL
receptor-induced	NULL
IL-2	NULL
expression	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
22-24	NULL
)	NULL
.	NULL

Thus	NULL
it	NULL
appears	NULL
that	NULL
CN	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
transducing	NULL
T	NULL
cell	NULL
receptor-mediated	NULL
signals	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
whether	NULL
the	NULL
influence	NULL
of	NULL
CN	NULL
on	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
cytosolic	NULL
forms	NULL
of	NULL
NFAT	NULL
is	NULL
due	NULL
to	NULL
a	NULL
direct	NULL
or	NULL
indirect	NULL
interaction	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
show	NULL
that	NULL
purified	NULL
bovine	NULL
CN	NULL
immobilized	NULL
to	NULL
calmodulin	NULL
Sepharose	NULL
beads	NULL
precipitates	NULL
NFATp	NULL
from	NULL
lysates	NULL
of	NULL
a	NULL
murine	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
CN	NULL
associated	NULL
with	NULL
both	NULL
the	NULL
phosphorylated	NULL
as	NULL
well	NULL
as	NULL
the	NULL
dephosphorylated	NULL
form	NULL
of	NULL
NFATp	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
CN	NULL
with	NULL
NFATp	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
complex	NULL
of	NULL
FK506-FKBP12	NULL
but	NULL
not	NULL
by	NULL
either	NULL
FK506	NULL
or	NULL
FKBP12	NULL
alone	NULL
.	NULL

The	NULL
finding	NULL
of	NULL
a	NULL
physical	NULL
association	NULL
of	NULL
CN	NULL
with	NULL
NFATp	NULL
supports	NULL
a	NULL
model	NULL
whereby	NULL
CN	NULL
is	NULL
directly	NULL
involved	NULL
in	NULL
dephosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NFATp	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells-The	NULL
CD4*	NULL
CD8*	NULL
murine	NULL
T	NULL
cell	NULL
hybridoma	NULL
BYDP	NULL
(	NULL
25	NULL
)	NULL
was	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
complete	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
5	NULL
%	NULL
iron-supplemented	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
units	NULL
of	NULL
penicillin/streptomycin	NULL
,	NULL
and	NULL
2	NULL
X	NULL
10	NULL
``	NULL
M	NULL
B-mer-captoethanol	NULL
)	NULL
.	NULL

Four	NULL
hours	NULL
prior	NULL
to	NULL
stimulation	NULL
,	NULL
BYDP	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
placed	NULL
in	NULL
serum-free	NULL
medium	NULL
(	NULL
same	NULL
as	NULL
complete	NULL
RPMI	NULL
1640	NULL
me-dium	NULL
,	NULL
except	NULL
without	NULL
serum	NULL
)	NULL
.	NULL

Inhibition	NULL
and	NULL
Stimulation	NULL
of	NULL
T	NULL
Cell	NULL
Hybridoma-BYDP	NULL
(	NULL
10	NULL
``	NULL
cells/	NULL
sample	NULL
)	NULL
were	NULL
washed	NULL
once	NULL
and	NULL
transferred	NULL
to	NULL
1.5-ml	NULL
microcentrifuge	NULL
tubes	NULL
and	NULL
incubated	NULL
with	NULL
FK506	NULL
(	NULL
0.1	NULL
uM	NULL
)	NULL
with	NULL
or	NULL
without	NULL
rapamycin	NULL
1274	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Physical	NULL
Interaction	NULL
of	NULL
Calcineurin	NULL
with	NULL
NFATp	NULL
1275	NULL
(	NULL
10	NULL
pM	NULL
)	NULL
or	NULL
with	NULL
ethanol	NULL
as	NULL
control	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Subsequently	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
or	NULL
as	NULL
indicated	NULL
)	NULL
and/or	NULL
ionomycin	NULL
(	NULL
2	NULL
pM	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Control	NULL
samples	NULL
were	NULL
adjusted	NULL
to	NULL
a	NULL
similar	NULL
concentration	NULL
of	NULL
the	NULL
diluent	NULL
ethanol	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pelleted	NULL
by	NULL
a	NULL
pulse	NULL
spin	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
50	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
10	NULL
pm	NULL
CaCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
pyrophosphate	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
and	NULL
proteinase	NULL
inhibitors	NULL
(	NULL
60	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
60	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
10	NULL
ug/ml	NULL
pepstatin	NULL
A	NULL
,	NULL
200	NULL
ug/ml	NULL
trypsin	NULL
inhibitor	NULL
,	NULL
17	NULL
ug/ml	NULL
calpain	NULL
inhibitor	NULL
I	NULL
,	NULL
7	NULL
ug/ml	NULL
calpain	NULL
inhibitor	NULL
II	NULL
,	NULL
50	NULL
ug/ml	NULL
antipain	NULL
,	NULL
50	NULL
ug/ml	NULL
chymostatin	NULL
,	NULL
25	NULL
ug/ml	NULL
bestatin	NULL
,	NULL
10	NULL
pg/ml	NULL
E64	NULL
,	NULL
100	NULL
ug/ml	NULL
phosphoramidon	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
)	NULL
.	NULL

Precipitation	NULL
and	NULL
Immunoblotting-Calmodulin-Sepharose	NULL
beads	NULL
were	NULL
washed	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
containing	NULL
1	NULL
mM	NULL
CaCl	NULL
,	NULL
and	NULL
preincubated	NULL
with	NULL
4	NULL
pM	NULL
(	NULL
or	NULL
as	NULL
indicated	NULL
)	NULL
FK506	NULL
and/or	NULL
400	NULL
uM	NULL
rapamycin	NULL
and	NULL
4	NULL
um	NULL
FKBP12	NULL
or	NULL
GST-FKBP12	NULL
and	NULL
0.2	NULL
pM	NULL
calcineurin	NULL
for	NULL
60	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
250	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
.	NULL

Subsequently	NULL
500-ul	NULL
lysates	NULL
of	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Beads	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
precipitation	NULL
wash	NULL
buffer	NULL
(	NULL
0.2	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mm	NULL
CaCl	NULL
,	NULL
,	NULL
5	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
4	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
4	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
1	NULL
ug/ml	NULL
pepstatin	NULL
A	NULL
,	NULL
30	NULL
ug/ml	NULL
trypsin	NULL
inhibitor	NULL
)	NULL
.	NULL

For	NULL
postincubation	NULL
of	NULL
beads	NULL
with	NULL
FKBP12-FK506	NULL
,	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
before	NULL
adding	NULL
40	NULL
uM	NULL
FK506	NULL
and	NULL
4	NULL
um	NULL
FKBP12	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
250	NULL
pl	NULL
of	NULL
precipitation	NULL
wash	NULL
buffer	NULL
and	NULL
washed	NULL
additionally	NULL
two	NULL
times	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
.	NULL

Proteins	NULL
bound	NULL
to	NULL
calmodulin-Sepharose	NULL
beads	NULL
were	NULL
separated	NULL
by	NULL
8-12	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
(	NULL
Millipore	NULL
Corp.	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
immunoblotted	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
,	NULL
and	NULL
developed	NULL
by	NULL
the	NULL
enhanced	NULL
chemi-luminescence	NULL
(	NULL
ECL	NULL
)	NULL
system	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

Reagents-CsA	NULL
is	NULL
produced	NULL
by	NULL
Sandoz	NULL
(	NULL
East	NULL
Hanover	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
FK506	NULL
by	NULL
Fujisawa	NULL
(	NULL
Melrose	NULL
Park	NULL
,	NULL
IL	NULL
)	NULL
,	NULL
and	NULL
rapamycin	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
J.	NULL
Johnson	NULL
(	NULL
NIH	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Ionomycin	NULL
was	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
and	NULL
PMA	NULL
from	NULL
Sigma	NULL
.	NULL

Proteinase	NULL
inhib-itors	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
trypsin	NULL
inhibitor	NULL
which	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
,	NULL
were	NULL
acquired	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
(	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Calmodulin-Sepharose	NULL
beads	NULL
were	NULL
obtained	NULL
from	NULL
Pharma-cia	NULL
Biotech	NULL
Inc	NULL
.	NULL

Bovine	NULL
brain	NULL
calcineurin	NULL
and	NULL
human	NULL
,	NULL
recombinant	NULL
FKBP12	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
.	NULL

The	NULL
fusion	NULL
protein	NULL
GST-FKBP12	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Rabbit	NULL
anti-peptide	NULL
antiserum	NULL
specific	NULL
for	NULL
FKBP12	NULL
(	NULL
amino	NULL
acids	NULL
1-16	NULL
)	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
M.	NULL
Harding	NULL
(	NULL
Vertex	NULL
Pharmaceuticals	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
rabbit	NULL
antiserum	NULL
against	NULL
NFATp	NULL
(	NULL
R59	NULL
)	NULL
was	NULL
generated	NULL
by	NULL
immunizing	NULL
rabbits	NULL
with	NULL
purified	NULL
recombinant	NULL
NFAT	NULL
p	NULL
and	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Rao	NULL
(	NULL
13	NULL
)	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Stimulation	NULL
of	NULL
T	NULL
Cells	NULL
with	NULL
Calcium	NULL
Ionophore	NULL
Induces	NULL
a	NULL
Shift	NULL
in	NULL
Relative	NULL
Mobility	NULL
of	NULL
NFATp-Murine	NULL
hybridoma	NULL
T	NULL
cells	NULL
(	NULL
BYDP	NULL
)	NULL
were	NULL
stimulated	NULL
for	NULL
5	NULL
min	NULL
with	NULL
the	NULL
calcium	NULL
iono-phore	NULL
,	NULL
ionomycin	NULL
,	NULL
the	NULL
protein	NULL
kinase	NULL
C-activating	NULL
phorbol	NULL
es-ter	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
with	NULL
both	NULL
agents	NULL
.	NULL

Whole	NULL
cell	NULL
lysates	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
an	NULL
antiserum	NULL
raised	NULL
against	NULL
NFATp	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Two	NULL
major	NULL
forms	NULL
of	NULL
NFAT	NULL
p	NULL
were	NULL
visualized	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

In	NULL
unstimulated	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
alone	NULL
,	NULL
NFAT	NULL
p	NULL
had	NULL
an	NULL
molecular	NULL
mass	NULL
of	NULL
~134	NULL
kDa	NULL
.	NULL

Stimulation	NULL
with	NULL
ionomycin	NULL
or	NULL
ionomycin	NULL
plus	NULL
PMA	NULL
induced	NULL
a	NULL
downward	NULL
shift	NULL
in	NULL
the	NULL
molecular	NULL
mass	NULL
of	NULL
NFAT	NULL
p	NULL
to	NULL
a	NULL
band	NULL
of	NULL
~113	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
this	NULL
shift	NULL
has	NULL
been	NULL
previously	NULL
demonstrated	NULL
to	NULL
be	NULL
due	NULL
to	NULL
the	NULL
dephosphorylation	NULL
of	NULL
NFATp	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

PMA	NULL
alone	NULL
did	NULL
not	NULL
elicit	NULL
a	NULL
shift	NULL
in	NULL
mobility	NULL
of	NULL
NFATp	NULL
,	NULL
indicating	NULL
that	NULL
a	NULL
rise	NULL
in	NULL
intracellular	NULL
calcium	NULL
concentration	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
dephosphorylation	NULL
of	NULL
NFATp	NULL
.	NULL

In	NULL
order	NULL
to	NULL
evaluate	NULL
the	NULL
time	NULL
course	NULL
of	NULL
the	NULL
dephosphorylation	NULL
of	NULL
NFATp	NULL
,	NULL
T	NULL
hybridoma	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
;	NULL
whole	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
,	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
NFATp-antiserum	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
ionomycin	NULL
induced	NULL
a	NULL
rapid	NULL
shift	NULL
in	NULL
mobility	NULL
of	NULL
NFATp	NULL
after	NULL
5	NULL
min	NULL
,	NULL
which	NULL
was	NULL
maintained	NULL
for	NULL
8	NULL
h	NULL
in	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
ionomycin	NULL
and	NULL
reverted	NULL
to	NULL
the	NULL
slower	NULL
migrating	NULL
,	NULL
phosphorylated	NULL
form	NULL
after	NULL
19	NULL
h.	NULL
The	NULL
rephosphorylation	NULL
of	NULL
NFATp	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
5	NULL
h	NULL
after	NULL
T	NULL
cell	NULL
receptor	NULL
activation	NULL
NFATp	NULL
translocates	NULL
to	NULL
o	NULL
£	NULL
Cee	NULL
w	NULL
©	NULL
8	NULL
&	NULL
A	NULL
$	NULL
6	NULL
#	NULL
#	NULL
#	NULL
0	NULL
0	NULL
.	NULL

«	NULL
ie	NULL
<	NULL
-116	NULL
-	NULL
8zzZ°7°	NULL
nratp	NULL
97	NULL
wod	NULL
bbbcczzcczcgfﬁ	NULL
o	NULL
is	NULL
-	NULL
N	NULL
®	NULL
-	NULL
m	NULL
so	NULL
in	NULL
om	NULL
c	NULL
,	NULL
-	NULL
t	NULL
O	NULL
.	NULL

4	NULL
a	NULL
as	NULL
me	NULL
me	NULL
ae	NULL
+-115-	NULL
Lo	NULL
_	NULL
``	NULL
``	NULL
*	NULL
``	NULL
``	NULL
a7-	NULL
A	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Increase	NULL
in	NULL
intracellular	NULL
Ca**	NULL
induces	NULL
the	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
p.	NULL
A	NULL
,	NULL
T	NULL
cells	NULL
(	NULL
BYDP	NULL
)	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
5	NULL
min	NULL
with	NULL
2	NULL
pM	NULL
ionomycin	NULL
(	NULL
Foro	NULL
)	NULL
,	NULL
5	NULL
ng/ml	NULL
PMA	NULL
,	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
both	NULL
.	NULL

B	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
time	NULL
with	NULL
2	NULL
pM	NULL
ionomycin	NULL
.	NULL

Whole	NULL
cell	NULL
lysates	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
NFATp	NULL
antiserum	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
putative	NULL
phosphorylated	NULL
and	NULL
dephosphorylated	NULL
forms	NULL
of	NULL
NFATp	NULL
.	NULL

The	NULL
band	NULL
between	NULL
both	NULL
arrows	NULL
was	NULL
detected	NULL
in	NULL
whole	NULL
cell	NULL
lysates	NULL
only	NULL
but	NULL
not	NULL
in	NULL
precipitations	NULL
(	NULL
see	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Molecular	NULL
size	NULL
markers	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
of	NULL
all	NULL
figures	NULL
.	NULL

the	NULL
cytoplasm	NULL
and	NULL
is	NULL
rephosphorylated	NULL
.	NULL

*	NULL
Calcineurin	NULL
Associates	NULL
with	NULL
Both	NULL
M	NULL
,	NULL
Forms	NULL
of	NULL
NFATp	NULL
in	NULL
Vitro-Calcineurin	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
dephosphorylation	NULL
and	NULL
subsequent	NULL
translocation	NULL
of	NULL
NFAT	NULL
p	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
since	NULL
inhibition	NULL
of	NULL
calcineurin	NULL
activity	NULL
by	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
FK506	NULL
and	NULL
CsA	NULL
inhibits	NULL
nuclear	NULL
translocation	NULL
of	NULL
cytosolic	NULL
NFAT	NULL
(	NULL
11	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
NFATp	NULL
,	NULL
in	NULL
T	NULL
cell	NULL
lysates	NULL
(	NULL
BYDP	NULL
cells	NULL
)	NULL
,	NULL
associates	NULL
with	NULL
exogenous	NULL
calcineurin	NULL
in	NULL
vitro	NULL
.	NULL

T	NULL
cell	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
purified	NULL
calcineurin	NULL
from	NULL
bovine	NULL
brain	NULL
immobilized	NULL
to	NULL
calmodulin-Sepharose	NULL
(	NULL
CaM	NULL
beads	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
inhibit	NULL
phosphatase	NULL
activity	NULL
of	NULL
CN	NULL
we	NULL
included	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
sodium	NULL
fluoride	NULL
and	NULL
sodium	NULL
pyrophosphate	NULL
during	NULL
incubation	NULL
.	NULL

In	NULL
lysates	NULL
of	NULL
unstimulated	NULL
T	NULL
cells	NULL
,	NULL
CN	NULL
bound	NULL
to	NULL
the	NULL
higher	NULL
(	NULL
phosphorylated	NULL
)	NULL
M	NULL
,	NULL
form	NULL
of	NULL
NFATp	NULL
whereas	NULL
in	NULL
lysates	NULL
of	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
CN	NULL
associated	NULL
with	NULL
the	NULL
lower	NULL
(	NULL
dephosphorylated	NULL
)	NULL
form	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
immobilized	NULL
CN	NULL
bound	NULL
both	NULL
phosphorylated	NULL
and	NULL
dephosphorylated	NULL
forms	NULL
of	NULL
NFATp	NULL
.	NULL

CN	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
was	NULL
inhibited	NULL
in	NULL
vivo	NULL
by	NULL
preincubating	NULL
T	NULL
cells	NULL
with	NULL
FK506	NULL
,	NULL
and	NULL
this	NULL
resulted	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
activation-induced	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
.	NULL

When	NULL
rapamycin	NULL
was	NULL
added	NULL
in	NULL
a	NULL
100-fold	NULL
excess	NULL
to	NULL
FK506	NULL
,	NULL
the	NULL
FK506-mediated	NULL
inhibition	NULL
of	NULL
NFATp	NULL
dephosphorylation	NULL
was	NULL
reversed	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Since	NULL
rapamycin	NULL
and	NULL
FK506	NULL
bind	NULL
competitively	NULL
to	NULL
FKBP12	NULL
,	NULL
but	NULL
the	NULL
complex	NULL
of	NULL
rapamycin~FKBP12	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
CN	NULL
(	NULL
2	NULL
)	NULL
,	NULL
the	NULL
reversal	NULL
by	NULL
rapamycin	NULL
of	NULL
FK506-mediated	NULL
inhibition	NULL
of	NULL
the	NULL
stimulation-induced	NULL
shift	NULL
of	NULL
NFAT	NULL
p	NULL
supports	NULL
the	NULL
involvement	NULL
of	NULL
CN	NULL
in	NULL
the	NULL
dephosphorylation	NULL
of	NULL
NFATp	NULL
in	NULL
vivo	NULL
.	NULL

Preincubation	NULL
of	NULL
CN/CaM	NULL
Beads	NULL
with	NULL
Exogenous	NULL
FK506	NULL
:	NULL
FKBP12	NULL
in	NULL
Vitro	NULL
Inhibits	NULL
NFATp	NULL
Binding	NULL
to	NULL
CN-It	NULL
has	NULL
previously	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
complex	NULL
of	NULL
FK506	NULL
with	NULL
its	NULL
intracellular	NULL
ligand	NULL
FKBP12	NULL
binds	NULL
to	NULL
and	NULL
inhibits	NULL
the	NULL
phosphatase	NULL
activity	NULL
of	NULL
CN	NULL
in	NULL
vitro	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Since	NULL
we	NULL
could	NULL
demonstrate	NULL
a	NULL
physical	NULL
interaction	NULL
of	NULL
CN	NULL
with	NULL
NFATp	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
FK506-FKBP12	NULL
complex	NULL
on	NULL
the	NULL
association	NULL
of	NULL
CN	NULL
and	NULL
NFATp	NULL
in	NULL
vitro	NULL
.	NULL

CaM	NULL
beads	NULL
were	NULL
incubated	NULL
with	NULL
purified	NULL
2	NULL
C.	NULL
Loh	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
1276	NULL
Physical	NULL
Interaction	NULL
of	NULL
Calcineurin	NULL
with	NULL
NFATp	NULL
Precipitation	NULL
CaM	NULL
CaM/CN	NULL
Post-Incubation	NULL
Pre-Incubation	NULL
FABP	NULL
Inhibition	NULL
F	NULL
A+F	NULL
Stimulation	NULL
-o	NULL
&	NULL
|-	NULL
&	NULL
|	NULL
-	NULL
&	NULL
|	NULL
-	NULL
#	NULL
|-	NULL
4	NULL
|	NULL
-	NULL
+	NULL
#	NULL
0	NULL
00	NULL
0	NULL
0	NULL
0	NULL
C	NULL
sone	NULL
cme	NULL
*~	NULL
NFAT	NULL
116-	NULL
CaZT	NULL
ZT	NULL
Ba	NULL
_	NULL
Se	NULL
-~	NULL
``	NULL
97	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Calcineurin	NULL
associates	NULL
with	NULL
phosphorylated	NULL
and	NULL
dephosphorylated	NULL
NFATp	NULL
and	NULL
FK506-FKBP12	NULL
inhibits	NULL
this	NULL
interaction	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
immunosuppressants	NULL
FK506	NULL
(	NULL
F	NULL
,	NULL
0.1	NULL
pM	NULL
)	NULL
,	NULL
0.1	NULL
um	NULL
FK506	NULL
plus	NULL
10	NULL
uM	NULL
rapamycin	NULL
(	NULL
R+F	NULL
)	NULL
,	NULL
or	NULL
in	NULL
medium	NULL
with	NULL
ethanol	NULL
(	NULL
0.2	NULL
%	NULL
)	NULL
as	NULL
diluent	NULL
control	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Subsequently	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
ionomycin	NULL
(	NULL
2	NULL
uM	NULL
)	NULL
and	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
or	NULL
ethanol	NULL
control	NULL
(	NULL
0.2	NULL
%	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Activated	NULL
(	NULL
+	NULL
)	NULL
or	NULL
nonactivated	NULL
(	NULL
-	NULL
)	NULL
cells	NULL
were	NULL
lysed	NULL
.	NULL

500	NULL
pl	NULL
of	NULL
lysates	NULL
were	NULL
added	NULL
to	NULL
calmodulin-Sepharose	NULL
beads	NULL
(	NULL
CaM	NULL
)	NULL
that	NULL
had	NULL
been	NULL
preincubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
or	NULL
without	NULL
purified	NULL
CN	NULL
(	NULL
0.2	NULL
uM	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
FK506	NULL
(	NULL
F	NULL
,	NULL
40	NULL
um	NULL
)	NULL
and	NULL
purified	NULL
FKBP12	NULL
(	NULL
BP	NULL
,	NULL
4	NULL
pM	NULL
)	NULL
or	NULL
ethanol	NULL
control	NULL
(	NULL
4	NULL
%	NULL
)	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
250	NULL
ul	NULL
.	NULL

After	NULL
an	NULL
additional	NULL
60-min	NULL
incubation	NULL
,	NULL
calmodulin-Sepharose	NULL
beads	NULL
and	NULL
associated	NULL
proteins	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
FK506	NULL
plus	NULL
FKBP12	NULL
(	NULL
F+BP	NULL
)	NULL
or	NULL
ethanol	NULL
in	NULL
the	NULL
same	NULL
concentrations	NULL
and	NULL
volume	NULL
as	NULL
during	NULL
preincubation	NULL
.	NULL

After	NULL
additional	NULL
washes	NULL
precipitated	NULL
proteins	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
NFATp	NULL
antiserum	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
phosphorylated	NULL
and	NULL
dephosphorylated	NULL
forms	NULL
of	NULL
precipitated	NULL
NFAT	NULL
p.	NULL
CN	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
FK506	NULL
and	NULL
purified	NULL
FKBP12	NULL
before	NULL
adding	NULL
lysates	NULL
of	NULL
stimulated	NULL
or	NULL
unstimulated	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
was	NULL
observed	NULL
that	NULL
once	NULL
the	NULL
complex	NULL
of	NULL
CN	NULL
,	NULL
FKBP12	NULL
,	NULL
and	NULL
FK506	NULL
was	NULL
formed	NULL
,	NULL
NFAT	NULL
p	NULL
from	NULL
either	NULL
unactivated	NULL
or	NULL
activated	NULL
T	NULL
cell	NULL
lysates	NULL
could	NULL
no	NULL
longer	NULL
bind	NULL
to	NULL
CN	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
once	NULL
NFATp	NULL
was	NULL
associated	NULL
with	NULL
CN	NULL
in	NULL
vitro	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
FK506-FKBP12	NULL
complex	NULL
could	NULL
not	NULL
disrupt	NULL
this	NULL
interaction	NULL
.	NULL

Specifically	NULL
,	NULL
NFATp	NULL
bound	NULL
to	NULL
CN/CaM	NULL
beads	NULL
could	NULL
not	NULL
be	NULL
``	NULL
eluted	NULL
``	NULL
with	NULL
FK506-FKBP12	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
assess	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
FK506	NULL
:	NULL
FKBP12-me-diated	NULL
inhibition	NULL
of	NULL
NFATp	NULL
to	NULL
CN	NULL
,	NULL
rapamycin	NULL
was	NULL
added	NULL
in	NULL
100-fold	NULL
excess	NULL
to	NULL
FK506	NULL
during	NULL
preincubation	NULL
of	NULL
CN/CaM	NULL
beads	NULL
and	NULL
GST-FKBP12	NULL
with	NULL
or	NULL
without	NULL
FK506	NULL
.	NULL

After	NULL
prein-cubation	NULL
,	NULL
lysates	NULL
of	NULL
activated	NULL
or	NULL
nonactivated	NULL
T	NULL
cells	NULL
were	NULL
added	NULL
,	NULL
and	NULL
proteins	NULL
associated	NULL
with	NULL
CN/CaM	NULL
beads	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
blotted	NULL
with	NULL
anti-NFATp	NULL
,	NULL
anti-CN	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
or	NULL
anti-FKBP12	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Preincubation	NULL
of	NULL
CN/CaM	NULL
beads	NULL
with	NULL
FK506	NULL
and	NULL
FKBP12	NULL
(	NULL
GST-FKBP12	NULL
)	NULL
led	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
FK506-FKBP12	NULL
to	NULL
CN	NULL
and	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
interaction	NULL
of	NULL
CN	NULL
with	NULL
NFATp	NULL
.	NULL

Only	NULL
the	NULL
combination	NULL
of	NULL
both	NULL
FKBP12	NULL
plus	NULL
FK506	NULL
blocked	NULL
the	NULL
binding	NULL
of	NULL
NFATp	NULL
to	NULL
CN	NULL
;	NULL
neither	NULL
drug	NULL
nor	NULL
immunophilin	NULL
alone	NULL
had	NULL
any	NULL
effect	NULL
on	NULL
the	NULL
association	NULL
nor	NULL
did	NULL
rapamycin~FKBP12	NULL
.	NULL

Inhibition	NULL
by	NULL
FK506-FKBP12	NULL
was	NULL
mediated	NULL
by	NULL
blocking	NULL
the	NULL
binding	NULL
of	NULL
CN	NULL
to	NULL
NFATp	NULL
and	NULL
not	NULL
by	NULL
disturbing	NULL
the	NULL
interaction	NULL
of	NULL
CN	NULL
with	NULL
CaM	NULL
,	NULL
since	NULL
immunoblots	NULL
for	NULL
CN	NULL
revealed	NULL
no	NULL
loss	NULL
of	NULL
CN	NULL
(	NULL
pre-cipitated	NULL
via	NULL
CaM	NULL
beads	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
FK506	NULL
:	NULL
-FKBP12	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
rapamycin	NULL
in	NULL
100-fold	NULL
excess	NULL
to	NULL
FK506	NULL
restored	NULL
the	NULL
association	NULL
of	NULL
NFAT	NULL
p	NULL
to	NULL
CN	NULL
,	NULL
thus	NULL
reversing	NULL
the	NULL
effect	NULL
of	NULL
FK506-FKBP12	NULL
on	NULL
the	NULL
CN/NFATp	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
presence	NULL
of	NULL
FK506	NULL
is	NULL
necessary	NULL
for	NULL
optimal	NULL
binding	NULL
of	NULL
FKBP12	NULL
to	NULL
CN	NULL
some	NULL
binding	NULL
of	NULL
FKBP12	NULL
alone	NULL
to	NULL
CN/CaM	NULL
beads	NULL
was	NULL
noted	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
FK506-FKBP12	NULL
inhibits	NULL
the	NULL
phosphatase	NULL
activity	NULL
of	NULL
CN	NULL
on	NULL
protein/peptide	NULL
substrates	NULL
but	NULL
not	NULL
on	NULL
small	NULL
organic	NULL
substrates	NULL
such	NULL
as	NULL
para-nitrophenyl	NULL
phosphate	NULL
(	NULL
2	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
the	NULL
complex	NULL
of	NULL
FK506-FKBP12	NULL
inhibits	NULL
substrate	NULL
binding	NULL
to	NULL
CN	NULL
rather	NULL
than	NULL
affecting	NULL
the	NULL
phosphatase	NULL
activity	NULL
of	NULL
CN	NULL
.	NULL

It	NULL
further	NULL
implies	NULL
that	NULL
the	NULL
catalytic	NULL
domain	NULL
of	NULL
CN	NULL
consists	NULL
of	NULL
at	NULL
least	NULL
two	NULL
sites	NULL
:	NULL
a	NULL
substrate-binding	NULL
site	NULL
and	NULL
a	NULL
catalytic	NULL
site	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
(	NULL
i	NULL
)	NULL
CN	NULL
binds	NULL
both	NULL
the	NULL
phosphorylated	NULL
and	NULL
dephosphorylated	NULL
forms	NULL
of	NULL
NFAT	NULL
p	NULL
and	NULL
Precipitation	NULL
:	NULL
_	NULL
CaM	NULL
CaM/CN	NULL
--	NULL
P	NULL
é	NULL
:	NULL
&	NULL
re-	NULL
soR8	NULL
o	NULL
$	NULL
$	NULL
a	NULL
$	NULL
#	NULL
8	NULL
$	NULL
$	NULL
R	NULL
&	NULL
&	NULL
Incubation	NULL
:	NULL
$	NULL
3	NULL
35	NULL
«	NULL
g	NULL
?	NULL

?	NULL

—	NULL
£134	NULL
:	NULL
5g	NULL
A	NULL
;	NULL
&	NULL
$	NULL
_	NULL
&	NULL
48	NULL
#	NULL
#	NULL
&	NULL
_£	NULL
r	NULL
--	NULL
r	NULL
e	NULL
Stimulation	NULL
:	NULL
mom	NULL
e	NULL
&	NULL
R	NULL
$	NULL
-	NULL
&	NULL
~	NULL
#	NULL
-	NULL
#	NULL
o-	NULL
+	NULL
#	NULL
200	NULL
A	NULL
116-	NULL
®	NULL
a	NULL
C	NULL
as	NULL
I	NULL
as	NULL
&	NULL
as	NULL
W	NULL
an	NULL
i=	NULL
urats	NULL
Anti-NFAT	NULL
_	NULL
Blot	NULL
45-B	NULL
Cue	NULL
--	NULL
-	NULL
+-	NULL
GST-FKBP12	NULL
34~	NULL
Anti-FKBP12	NULL
-	NULL
Blot	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Rapamycin	NULL
restores	NULL
the	NULL
FK506-FKBP12-inhibited	NULL
association	NULL
of	NULL
CN	NULL
with	NULL
NFATp	NULL
.	NULL

A	NULL
,	NULL
500-4ul	NULL
lysates	NULL
of	NULL
activated	NULL
(	NULL
+	NULL
)	NULL
or	NULL
nonactivated	NULL
(	NULL
-	NULL
)	NULL
T	NULL
cells	NULL
(	NULL
stimulated	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
were	NULL
added	NULL
to	NULL
calmodulin-Sepharose	NULL
beads	NULL
that	NULL
had	NULL
been	NULL
preincubated	NULL
for	NULL
60	NULL
min	NULL
with	NULL
or	NULL
without	NULL
purified	NULL
CN	NULL
(	NULL
0.2	NULL
uM	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
FK506	NULL
(	NULL
4	NULL
pM	NULL
)	NULL
,	NULL
rapamycin	NULL
(	NULL
Rapa	NULL
,	NULL
400	NULL
uM	NULL
)	NULL
,	NULL
ethanol	NULL
(	NULL
4	NULL
%	NULL
)	NULL
as	NULL
control	NULL
,	NULL
and/or	NULL
purified	NULL
GST-FKBP12	NULL
(	NULL
4	NULL
pM	NULL
)	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
250	NULL
ul	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
an	NULL
additional	NULL
60	NULL
min	NULL
,	NULL
calmodulin-Sepharose	NULL
beads	NULL
were	NULL
washed	NULL
,	NULL
and	NULL
precipitated	NULL
proteins	NULL
were	NULL
immunoblotted	NULL
with	NULL
NFATp	NULL
antiserum	NULL
or	NULL
FKBP12	NULL
antiserum	NULL
(	NULL
B	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
these	NULL
interactions	NULL
are	NULL
inhibited	NULL
by	NULL
FK506-FKBP12	NULL
supports	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
major	NULL
interaction	NULL
of	NULL
CN	NULL
with	NULL
NFAT	NULL
p	NULL
occurs	NULL
via	NULL
the	NULL
substrate-binding	NULL
site	NULL
rather	NULL
than	NULL
the	NULL
catalytic	NULL
site	NULL
.	NULL

The	NULL
recently	NULL
solved	NULL
x-ray	NULL
crystallographic	NULL
structure	NULL
of	NULL
FK506-FKBP12	NULL
bound	NULL
to	NULL
CN	NULL
revealed	NULL
that	NULL
the	NULL
FK506-FKBP12	NULL
complex	NULL
binds	NULL
to	NULL
the	NULL
A-chain	NULL
of	NULL
CN	NULL
at	NULL
a	NULL
site	NULL
approximately	NULL
10	NULL
A	NULL
removed	NULL
from	NULL
the	NULL
catalytic	NULL
site	NULL
(	NULL
27	NULL
)	NULL
.	NULL

This	NULL
structural	NULL
information	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
data	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
NFATp	NULL
with	NULL
the	NULL
catalytic	NULL
site	NULL
is	NULL
not	NULL
a	NULL
requirement	NULL
for	NULL
binding	NULL
.	NULL

Though	NULL
we	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
the	NULL
binding	NULL
of	NULL
NFAT	NULL
p	NULL
to	NULL
CN	NULL
,	NULL
we	NULL
could	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
of	NULL
a	NULL
third	NULL
protein	NULL
involved	NULL
in	NULL
this	NULL
interaction	NULL
.	NULL

While	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
CsA	NULL
and	NULL
FK506	NULL
inhibit	NULL
the	NULL
dephosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NFATp	NULL
,	NULL
it	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
demonstrated	NULL
whether	NULL
the	NULL
influence	NULL
of	NULL
CN	NULL
on	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
cytosolic	NULL
form	NULL
of	NULL
NFAT	NULL
is	NULL
due	NULL
to	NULL
a	NULL
direct	NULL
or	NULL
indirect	NULL
interaction	NULL
.	NULL

In	NULL
the	NULL
direct	NULL
model	NULL
,	NULL
CN	NULL
dephosphorylates	NULL
NFAT	NULL
directly	NULL
,	NULL
thereby	NULL
enabling	NULL
it	NULL
to	NULL
cross	NULL
the	NULL
nuclear	NULL
membrane	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
component	NULL
of	NULL
NFAT	NULL
would	NULL
be	NULL
regulated	NULL
by	NULL
dephosphorylation	NULL
,	NULL
as	NULL
has	NULL
been	NULL
shown	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
yeast	NULL
transcription	NULL
factor	NULL
SWI5	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Al-ternatively	NULL
,	NULL
the	NULL
indirect	NULL
model	NULL
takes	NULL
into	NULL
account	NULL
that	NULL
all	NULL
four	NULL
isoforms	NULL
of	NULL
the	NULL
cytosolic	NULL
component	NULL
of	NULL
NFAT	NULL
contain	NULL
a	NULL
region	NULL
similar	NULL
to	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
the	NULL
NFB	NULL
family	NULL
(	NULL
14-16	NULL
)	NULL
.	NULL

It	NULL
has	NULL
,	NULL
therefore	NULL
,	NULL
been	NULL
suggested	NULL
that	NULL
NFAT	NULL
in	NULL
nonactivated	NULL
T	NULL
cells	NULL
might	NULL
be	NULL
retained	NULL
by	NULL
a	NULL
cytosolic	NULL
anchoring	NULL
protein	NULL
,	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
as	NULL
NFB	NULL
is	NULL
retained	NULL
by	NULL
I	NULL
«	NULL
B	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Dephosphorylation	NULL
of	NULL
the	NULL
putative	NULL
anchoring	NULL
protein	NULL
by	NULL
CN	NULL
would	NULL
then	NULL
result	NULL
in	NULL
the	NULL
release	NULL
of	NULL
NFAT	NULL
and	NULL
its	NULL
subsequent	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
CN	NULL
associates	NULL
with	NULL
phosphorylated	NULL
and	NULL
dephosphorylated	NULL
NFATp	NULL
favors	NULL
a	NULL
model	NULL
of	NULL
a	NULL
direct	NULL
interaction	NULL
of	NULL
CN	NULL
with	NULL
NFATp	NULL
for	NULL
the	NULL
following	NULL
reasons	NULL
.	NULL

(	NULL
i	NULL
)	NULL
It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
dephosphorylated	NULL
NFATp	NULL
is	NULL
able	NULL
to	NULL
trans-locate	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

In	NULL
case	NULL
NFATp	NULL
is	NULL
released	NULL
from	NULL
a	NULL
cytosolic	NULL
anchoring	NULL
protein	NULL
after	NULL
activation	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
CN	NULL
associates	NULL
with	NULL
NFATp	NULL
via	NULL
a	NULL
cytosolic	NULL
anchoring	NULL
protein	NULL
,	NULL
since	NULL
NFATp	NULL
would	NULL
already	NULL
be	NULL
released	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
The	NULL
known	NULL
NFxB	NULL
anchoring	NULL
proteins	NULL
,	NULL
«	NULL
B	NULL
,	NULL
,	NULL
and	NULL
I	NULL
«	NULL
B	NULL
,	NULL
degrade	NULL
10	NULL
min	NULL
and	NULL
4	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
respectively	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
NFATp	NULL
takes	NULL
place	NULL
5-10	NULL
min	NULL
after	NULL
stimulation	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
if	NULL
NFATp	NULL
is	NULL
retained	NULL
in	NULL
the	NULL
cytosol	NULL
by	NULL
an	NULL
IxB-like	NULL
anchoring	NULL
protein	NULL
it	NULL
must	NULL
be	NULL
released	NULL
from	NULL
this	NULL
protein	NULL
and	NULL
from	NULL
CN	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Physical	NULL
Interaction	NULL
of	NULL
Calcineurin	NULL
with	NULL
NFATp	NULL
118	NULL
-	NULL
an	NULL
ap	NULL
an	NULL
#	NULL
#	NULL
an	NULL
ae	NULL
#	NULL
D	NULL
we	NULL
ae	NULL
<	NULL
-	NULL
NFATp	NULL
97	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

CN	NULL
associates	NULL
with	NULL
NFATp	NULL
up	NULL
to	NULL
6	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

CN/CaM-Sepharose	NULL
beads	NULL
were	NULL
incubated	NULL
with	NULL
500-pl	NULL
lysates	NULL
of	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
2	NULL
pM	NULL
ionomycin	NULL
for	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
time	NULL
.	NULL

After	NULL
a	NULL
60-min	NULL
incubation	NULL
,	NULL
calmodulin-Sepharose	NULL
beads	NULL
were	NULL
washed	NULL
,	NULL
and	NULL
precipitated	NULL
proteins	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
NFATp	NULL
antiserum	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
dephosphorylated	NULL
form	NULL
of	NULL
NFATp	NULL
.	NULL

within	NULL
5-10	NULL
min	NULL
.	NULL

Since	NULL
we	NULL
could	NULL
demonstrate	NULL
that	NULL
CN/CaM	NULL
beads	NULL
precipitate	NULL
NFATp	NULL
from	NULL
lysates	NULL
of	NULL
T	NULL
cells	NULL
stimulated	NULL
for	NULL
up	NULL
to	NULL
6	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
NFATp	NULL
would	NULL
still	NULL
associate	NULL
with	NULL
CN	NULL
via	NULL
an	NULL
I	NULL
«	NULL
B-like	NULL
protein	NULL
.	NULL

Therefore	NULL
,	NULL
our	NULL
observation	NULL
of	NULL
a	NULL
physical	NULL
interaction	NULL
of	NULL
CN	NULL
and	NULL
NFATp	NULL
,	NULL
together	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
phosphorylated	NULL
NFAT	NULL
p	NULL
can	NULL
serve	NULL
as	NULL
a	NULL
substrate	NULL
for	NULL
CN	NULL
in	NULL
vitro	NULL
(	NULL
21	NULL
)	NULL
,	NULL
supports	NULL
a	NULL
model	NULL
in	NULL
which	NULL
CN	NULL
is	NULL
directly	NULL
involved	NULL
in	NULL
the	NULL
dephosphorylation	NULL
and	NULL
subsequent	NULL
nuclear	NULL
translocation	NULL
of	NULL
NFATp	NULL
.	NULL

Acknowledgments-We	NULL
are	NULL
very	NULL
grateful	NULL
to	NULL
Dr.	NULL
A.	NULL
Rao	NULL
for	NULL
the	NULL
NFATp	NULL
antiserum	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
S.	NULL
Baksh	NULL
,	NULL
Dr.	NULL
J.-H.	NULL
Chang	NULL
,	NULL
Dr.	NULL
T.	NULL
Li	NULL
,	NULL
Dr.	NULL
A.	NULL
Rao	NULL
,	NULL
Dr.	NULL
K.	NULL
S.	NULL
Ravichandran	NULL
,	NULL
Dr.	NULL
S.	NULL
Sawasdikosol	NULL
,	NULL
and	NULL
Dr.	NULL
K.	NULL
T.-Y	NULL
.	NULL

Shaw	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

REFERENCES	NULL
.	NULL

Friedman	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Weissman	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
799-806	NULL
2	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
Farmer	NULL
,	NULL
J.	NULL
D.	NULL
J.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Friedman	NULL
,	NULL
J.	NULL
,	NULL
Weissman	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
807-815	NULL
3	NULL
.	NULL

Kronke	NULL
,	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Arya	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Waldmann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U	NULL
.	NULL

8	NULL
.	NULL

A	NULL
.	NULL

81	NULL
,	NULL
5214-5218	NULL
4	NULL
.	NULL

Tocci	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Matkovich	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Collier	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Kwok	NULL
,	NULL
P.	NULL
,	NULL
Dumont	NULL
,	NULL
F.	NULL
,	NULL
Lin	NULL
,	NULL
S.	NULL
,	NULL
Degudicibus	NULL
,	NULL
S.	NULL
,	NULL
Siekierka	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Chin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Hutchinson	NULL
,	NULL
N.	NULL
I	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
718-726	NULL
5	NULL
.	NULL

Bickel	NULL
,	NULL
M.	NULL
,	NULL
Tsuda	NULL
,	NULL
H.	NULL
,	NULL
Amstad	NULL
,	NULL
P.	NULL
,	NULL
Evequoz	NULL
,	NULL
V.	NULL
,	NULL
Mergenhagen	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Wahl	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Pluznik	NULL
,	NULL
D.	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Nafl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
3274-3277	NULL
6	NULL
.	NULL

Shaw	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Utz	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Toole	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
a	NULL
7	NULL
.	NULL

8	NULL
.	NULL

9	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15.	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
,	NULL
Naito	NULL
,	NULL
Y.	NULL
,	NULL
Tokumitsu	NULL
,	NULL
H.	NULL
,	NULL
Campbell	NULL
,	NULL
D.	NULL
,	NULL
Saito	NULL
,	NULL
F.	NULL
,	NULL
Hannum	NULL
,	NULL
C.	NULL
,	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19.	NULL
.	NULL

Shaw	NULL
,	NULL
K	NULL
.	NULL

T.-Y	NULL
.	NULL

,	NULL
Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Raghavan	NULL
,	NULL
A.	NULL
,	NULL
Kim	NULL
,	NULL
J.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Park	NULL
,	NULL
J.	NULL
,	NULL
Sharma	NULL
,	NULL
S.	NULL
,	NULL
21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28.	NULL
.	NULL

Moll	NULL
,	NULL
T.	NULL
,	NULL
Tebb	NULL
,	NULL
G.	NULL
,	NULL
Surana	NULL
,	NULL
U.	NULL
,	NULL
Robitsch	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Nasmyth	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

1277	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
202-205	NULL
Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Bert	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Ryan	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Vadas	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
2466-2470	NULL
Todd	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Grusby	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Lederer	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Lacy	NULL
,	NULL
E.	NULL
,	NULL
Lichtman	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177	NULL
,	NULL
1663-1674	NULL
Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Gold	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Murphy	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
and	NULL
Murphy	NULL
,	NULL
K.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
4793-4805	NULL
Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
1365-1379	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Valge-Arthur	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
356	NULL
,	NULL
801-804	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
2917-2923	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Badalian	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Burgeon	NULL
,	NULL
E.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
750-754	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Chen	NULL
,	NULL
L.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
869	NULL
,	NULL
497-502	NULL
Hoey	NULL
,	NULL
T.	NULL
,	NULL
Sun	NULL
,	NULL
Y.-L.	NULL
,	NULL
Wiliamson	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Xu	NULL
,	NULL
X	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
461-472	NULL
Arai	NULL
,	NULL
K.-L.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
2697-2706	NULL
Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Corthesy	NULL
,	NULL
B.	NULL
,	NULL
Bram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
852	NULL
,	NULL
803-807	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Perrino	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Soderling	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
3747-3752	NULL
Ruff	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
and	NULL
Leach	NULL
,	NULL
K.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
22602-22607	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
11205-11209	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Miner	NULL
,	NULL
Z.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
865	NULL
,	NULL
352-355	NULL
Fruman	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Klee	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Bierer	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
Burakoff	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
3686-3690	NULL
Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
857	NULL
,	NULL
695-697	NULL
O'Keefe	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Tamura	NULL
,	NULL
J.	NULL
,	NULL
Kincaid	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Tocci	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
O'Neill	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
357	NULL
,	NULL
692-694	NULL
Ravichandran	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
and	NULL
Burakoff	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
,	NULL
727-782	NULL
Jin	NULL
,	NULL
Y.-J	NULL
.	NULL

,	NULL
Burakoff	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Bierer	NULL
,	NULL
B.	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
10942-10945	NULL
Griffith	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Kim	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Kim	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
Sintchak	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Thomson	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Fitzgibbon	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Fleming	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Caron	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Hsiao	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Navia	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cell	NULL
82	NULL
,	NULL
507-522	NULL
Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
18	NULL
,	NULL
136-142	NULL
743-758	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2064-2070	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Clipstone	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

68	NULL
,	NULL
1045-1083	NULL
Thompson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Phillips	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Erdjument-Bromage	NULL
,	NULL
H.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Ghosh	NULL
,	NULL
9	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
573-582	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Identification	NULL
of	NULL
a	NULL
Physical	NULL
Interaction	NULL
between	NULL
Calcineurin	NULL
and	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
(	NULL
NFATp	NULL
)	NULL
Sebastian	NULL
Wesselborg	NULL
,	NULL
David	NULL
A.	NULL
Fruman	NULL
,	NULL
Jasbir	NULL
K.	NULL
Sagoo	NULL
,	NULL
Barbara	NULL
E.	NULL
Bierer	NULL
and	NULL
Steven	NULL
J.	NULL
Burakoff	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:1274-1277.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.3.1274	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/3/1274	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
32	NULL
references	NULL
,	NULL
18	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
274	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

